The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Will The Market Value Of The Machine Learning (ML) in The Pharmaceutical Industry Market Change Between 2026 And 2030?
The market size for machine learning (ML) within the pharmaceutical industry has expanded substantially in recent years. This market is projected to increase from $4.08 billion in 2025 to $5.52 billion in 2026, reflecting a compound annual growth rate (CAGR) of 35.4%. The growth observed in prior periods can be attributed to heightened research and development investment in pharmaceuticals, the integration of AI and ML into drug discovery, an increasing prevalence of chronic diseases, progress in computational biology, and partnerships forged between pharmaceutical and technology companies.
The market size for machine learning (ML) within the pharmaceutical industry is expected to show significant growth over the next few years. It is projected to reach $18.71 billion by 2030, with a compound annual growth rate (CAGR) of 35.7%. This growth during the forecast period is driven by the increasing integration of AI in clinical trials, the expansion of precision medicine, the rising use of real-world data analytics, advancements in cloud-based pharmaceutical platforms, and the development of personalized therapeutics. Prominent trends for this period include predictive drug discovery models, the optimization of clinical trials, the utilization of real-world evidence data, the implementation of personalized medicine, and automation in regulatory compliance.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13872&type=smp
Which Major Factors Are Contributing To The Development Of The Machine Learning (ML) in The Pharmaceutical Industry Market?
The growing implementation of artificial intelligence (AI) is fueling machine learning (ML) within the pharmaceutical sector. AI refers to computer software designed to simulate human thought processes for complex tasks, including analysis, reasoning, and learning, whereas ML, a subset of AI, utilizes algorithms trained on data to create models capable of performing intricate operations. Both AI and ML have found application in pharmaceutical technology and drug delivery design, providing rapid resolutions to difficult problems. These technologies possess the capacity to revolutionize drug delivery, improve tools for making decisions, and process vast data volumes for better outcomes. As an illustration, in June 2023, Forbes, a US-based business magazine, reported that approximately 432,000 UK organizations—equivalent to one in six—had integrated at least one AI technology. Furthermore, large businesses saw an adoption rate of 68% for at least one AI technology, with medium-sized businesses at 33% and small businesses at 15%. Consequently, the expanding implementation of artificial intelligence (AI) is set to propel machine learning (ML) forward in the pharmaceutical industry.
How Is The Machine Learning (ML) in The Pharmaceutical Industry Market Examined Through Segment Analysis?
The machine learning (ml) in the pharmaceutical industry market covered in this report is segmented –
1) By Component: Solution, Services
2) By Deployment: Cloud, On-premise
3) By Enterprise Size: Small and Medium Enterprises (SMEs), Large Enterprises
Subsegments:
1) By Solution: Drug Discovery Platforms, Predictive Analytics Tools, Clinical Trial Optimization Solutions, Patient Data Management Systems, Personalized Medicine Applications
2) By Services: Consulting Services, Implementation And Integration Services, Data Analysis And Modeling Services, Training And Support Services, Managed Services
Which Trends Are Influencing The Direction Of The Machine Learning (ML) in The Pharmaceutical Industry Market?
Major companies engaged in machine learning (ML) within the pharmaceutical industry are concentrating on developing user-friendly software platforms, such as drug discovery software, to enhance their drug discovery capabilities. Drug discovery software serves as a comprehensive term covering various specialized tools and platforms utilized across the entire process of identifying and developing novel pharmaceutical drugs. For instance, in December 2023, Merck & Co. Inc., a US-based pharmaceutical company, launched its AIDDISON drug discovery software. This represents the first software-as-a-service platform that integrates drug discovery and synthesis by leveraging generative AI, machine learning, and computer-aided drug design. The platform enables laboratories to identify appropriate drug candidates within a vast chemical space, virtually screen compounds from a universe of over 60 billion chemical targets, and evaluate synthesis routes for safer, more cost-effective, and higher-yield drug manufacturing.
Who Are The Major Companies Operating In The Machine Learning (ML) in The Pharmaceutical Industry Market?
Major companies operating in the machine learning (ml) in the pharmaceutical industry market are Amazon.com Inc., Alphabet Inc., Microsoft Corporation, Dell Technologies Inc., Hitachi Ltd., International Business Machines Corporation, Cisco Systems Inc., Oracle Corporation, Honeywell International Inc., Hewlett Packard Enterprise, NVIDIA Corporation, Thales SA, Atos SE, Hexagon AB, Palantir Technologies Inc., Alteryx Inc., Comet ML Inc., GAVS Technologies, NEC Corporation, Veritone Inc., H2O.ai Inc., Sparkcognition Inc., Akira AI, Deep Genomics Inc., Cloud Pharmaceuticals Inc., Atomwise Inc., Cyclica Inc., BioSymetrics Inc., Neptune Labs
Access The Complete Machine Learning (ML) in The Pharmaceutical Industry Market Report:
Which Region Is The Dominant Market In The Machine Learning (ML) in The Pharmaceutical Industry Market?
North America was the largest region in the machine learning in the pharmaceutical industry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the machine learning (ml) in the pharmaceutical industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Machine Learning (ML) in The Pharmaceutical Industry Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=13872&type=smp
Browse Through More Reports Similar to the Global Machine Learning (ML) in The Pharmaceutical Industry Market 2026, By The Business Research Company
Machine Learning Ml In The Pharmaceutical Industry Market Report 2026
Artificial Intelligence In Drug Discovery Market Report 2026
Artificial Intelligence Ai In Biopharmaceuticals Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model